EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

ASL, DSC, DCE perfusion MRI and 18F-DOPA PET/CT in differentiating glioma recurrence from post-treatment changes

Giulia Moltoni, Andrea Romano, Gabriela Capriotti, Giuseppe Campagna, Anna Maria Ascolese, Allegra Romano, Francesco Dellepiane, Giuseppe Minniti, Alberto Signore, Alessandro Bozzao

La radiologia medica · 2024

DOI: 10.1007/s11547-024-01862-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift La radiologia medica, 2024. Verfasst von Giulia Moltoni und 9 weiteren Autor:innen. Beteiligte Einrichtung: NESMOS, Department of Neuroradiology, S. Andrea Hospital, University Sapienza, Via di Grottarossa 1035/1039, 00189, Rome, Italy. giulia.moltoni@uniro…. Hauptthemen laut MEDLINE: Positron Emission Tomography Computed Tomography, Glioma, Neoplasm Recurrence, Local, Brain Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Università degli Studi di Roma La Sapienza.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To discriminate between post-treatment changes and tumor recurrence in patients affected by glioma undergoing surgery and chemoradiation with a new enhancing lesion is challenging. We aimed to evaluate the role of ASL, DSC, DCE perfusion MRI, and 18F-DOPA PET/CT in distinguishing tumor recurrence from post-treatment changes in patients with glioma. Materials and methods We prospectively enrolled patients with treated glioma (surgery plus chemoradiation) and a new enhancing lesion doubtful for recurrence or post-treatment changes. Each patient underwent a 1.5T MRI examination, including ASL, DSC, and DCE PWI, and an 18 F-DOPA PET/CT examination. For each lesion, we measured ASL-derived CBF and normalized CBF, DSC-derived rCBV, DCE-derived Ktrans, Vp, Ve, Kep, and PET/CT-derived SUV maximum. Clinical and radiological follow-up determined the diagnosis of tumor recurrence or post-treatment changes.

Results

We evaluated 29 lesions (5 low-grade gliomas and 24 high-grade gliomas); 14 were malignancies, and 15 were post-treatment changes. CBF ASL, nCBF ASL, rCBV DSC, and PET SUVmax were associated with tumor recurrence from post-treatment changes in patients with glioma through an univariable logistic regression. Whereas the multivariable logistic regression results showed only nCBF ASL ( p = 0.008) was associated with tumor recurrence from post-treatment changes in patients with glioma with OR = 22.85, CI95%: (2.28–228.77).

Conclusion

In our study, ASL was the best technique, among the other two MRI PWI and the 18F-DOPA PET/CT PET, in distinguishing disease recurrence from post-treatment changes in treated glioma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Positron Emission Tomography Computed TomographyGliomaNeoplasm Recurrence, LocalBrain NeoplasmsDihydroxyphenylalanineRadiopharmaceuticalsHumansMaleFemaleMiddle AgedProspective StudiesAdultAgedDiagnosis, DifferentialMagnetic Resonance ImagingContrast Media

Stichwörter der Autor:innen

GliomaMRI perfusionPETPost-treatment changesTumor recurrence

Substanzen

fluorodopa F 18DihydroxyphenylalanineRadiopharmaceuticalsContrast Media

Autor:innen und Institutionen

  • NESMOS, Department of Neuroradiology, S. Andrea Hospital, University Sapienza, Via di Grottarossa 1035/1039, 00189, Rome, Italy. giulia.moltoni@uniroma1.it.
  • NESMOS, Department of Neuroradiology, S. Andrea Hospital, University Sapienza, Via di Grottarossa 1035/1039, 00189, Rome, Italy.
  • Department of Medical-Surgical Sciences and Translational Medicine, University of Rome "Sapienza", Rome, Italy.
  • SMCMT Department, Radiotherapy Oncology, S. Andrea Hospital, University Sapienza, Rome, Italy.
  • Department of Radiological, Oncological and Pathological Sciences, "Sapienza" University of Rome, 00138, Rome, Italy.
  • IRCCS Neuromed, 86077, Pozzilli, Italy.

Förderung

  • Università degli Studi di Roma La Sapienza

Zitieren

APA

Moltoni, G., Romano, A., Capriotti, G., Campagna, G., Ascolese, A. M., Romano, A., Dellepiane, F., Minniti, G., Signore, A., & Bozzao, A. (2024). ASL, DSC, DCE perfusion MRI and 18F-DOPA PET/CT in differentiating glioma recurrence from post-treatment changes. La radiologia medica. https://doi.org/10.1007/s11547-024-01862-3

Vancouver

Moltoni G, Romano A, Capriotti G, Campagna G, Ascolese AM, Romano A, et al. ASL, DSC, DCE perfusion MRI and 18F-DOPA PET/CT in differentiating glioma recurrence from post-treatment changes. La radiologia medica. 2024. doi:10.1007/s11547-024-01862-3

BibTeX
@article{Moltoni2024,
  author = {Moltoni, Giulia and Romano, Andrea and Capriotti, Gabriela and Campagna, Giuseppe and Ascolese, Anna Maria and Romano, Allegra and Dellepiane, Francesco and Minniti, Giuseppe and Signore, Alberto and Bozzao, Alessandro},
  title = {ASL, DSC, DCE perfusion MRI and 18F-DOPA PET/CT in differentiating glioma recurrence from post-treatment changes},
  journal = {La radiologia medica},
  year = {2024},
  doi = {10.1007/s11547-024-01862-3}
}
Kostenlos starten →